LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare blood vessel disorders: targeted drugs enter trial

Disease control Recruiting now

This study tests two targeted drugs for people with vascular malformations (abnormal blood or lymph vessels). It includes 50 participants aged 2 and older. One group with slow-flow malformations and a specific gene mutation receives alpelisib for 48 weeks. Another group with fast…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control

Last updated Apr 29, 2026 06:26 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

New hope for rare blood vessel disorders: targeted drugs enter trial